- Home
- UMAC vs STXS Comparison
UMAC vs STXS Comparison
Compare UMAC & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UMAC
- STXS
- Stock Information
- Founded
- UMAC 2019
- STXS 1990
- Country
- UMAC United States
- STXS United States
- Employees
- UMAC N/A
- STXS N/A
- Industry
- UMAC
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- UMAC
- STXS Health Care
- Exchange
- UMAC Nasdaq
- STXS Nasdaq
- Market Cap
- UMAC 267.7M
- STXS 275.9M
- IPO Year
- UMAC 2024
- STXS 2004
- Fundamental
- Price
- UMAC $13.03
- STXS $3.11
- Analyst Decision
- UMAC Strong Buy
- STXS
- Analyst Count
- UMAC 3
- STXS 0
- Target Price
- UMAC $19.33
- STXS N/A
- AVG Volume (30 Days)
- UMAC 4.5M
- STXS 572.4K
- Earning Date
- UMAC 11-13-2025
- STXS 11-11-2025
- Dividend Yield
- UMAC N/A
- STXS N/A
- EPS Growth
- UMAC N/A
- STXS N/A
- EPS
- UMAC N/A
- STXS N/A
- Revenue
- UMAC $7,701,550.00
- STXS $31,806,000.00
- Revenue This Year
- UMAC $86.94
- STXS $30.98
- Revenue Next Year
- UMAC $118.95
- STXS $49.86
- P/E Ratio
- UMAC N/A
- STXS N/A
- Revenue Growth
- UMAC 279.38
- STXS 33.94
- 52 Week Low
- UMAC $1.43
- STXS $1.54
- 52 Week High
- UMAC $23.62
- STXS $3.59
- Technical
- Relative Strength Index (RSI)
- UMAC 51.49
- STXS 52.59
- Support Level
- UMAC $11.11
- STXS $2.95
- Resistance Level
- UMAC $13.18
- STXS $3.13
- Average True Range (ATR)
- UMAC 1.63
- STXS 0.18
- MACD
- UMAC -0.37
- STXS -0.02
- Stochastic Oscillator
- UMAC 37.51
- STXS 25.19
About UMAC Unusual Machines Inc. Common Stock
Unusual Machines Inc is engaged in serving the American drone industry by building and selling drone components.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.